Advertisement
Document › Details
Mologen AG. (4/20/18). "Press Release: Chief Executive Officer of Mologen AG Will Not Extend Executive Board Mandate Expiring in October 2018 (Ad-hoc News)". Berlin.
The CEO of the biopharmaceutical company MOLOGEN AG, Dr Mariola Soehngen, informed the Supervisory Board that she will not renew her position as member and Chief Executive Officer on the Board of Directors of MOLOGEN AG which expires on 31 October 2018.
The CEO of the biopharmaceutical company MOLOGEN AG, Dr Mariola Soehngen, informed the Supervisory Board that she will not renew her position as member and Chief Executive Officer on the Board of Directors of MOLOGEN AG which expires on 31 October 2018. MOLOGEN AG will immediately begin to look for a suitable successor. During a possible transition period until the appointment of a potential further member and Chairman of the Board of Directors, the remaining members of the Board of Directors will fulfil the tasks of the management to ensure continuity.
- End of ad-hoc notification -
Contact
Claudia Nickolaus
Head of Investor Relations & Corporate Communications
Tel: +49 - 30 - 84 17 88 – 38
Fax: +49 - 30 - 84 17 88 - 50
investor@mologen.com
Note about risk for future predictions
Certain information in this report contains forward-looking statements or the corresponding statements with negation or versions deviating from this or comparable terminology. These are described as forward-looking statements. In addition, all of the information given here that refers to planned or future results of business areas, key financial figures, developments of the financial situation or other financial figures or statistical data, is to be understood as such forward-looking statements. The company points out to investors that they should not rely on these forward-looking statements as predictions about actual future events. The company is not obligated and refuses to accept any liability for the forward-looking statements and has no obligation to update such statements in order to accurately reflect the current situation.
Record changed: 2023-06-05 |
Advertisement
More documents for Mologen (Group)
- [1] Mologen AG. (12/3/19). "Press Release: Insolvency Filing [Not for publication or distribution in or into US, AU, CA or JP or any jurisdiction in which unlawful]". Berlin....
- [2] Mologen AG. (8/5/19). "Press Release: Mologen AG Announces Top Line Data of Pivotal IMPALA Study in Metastatic Colorectal Cancer. Primary Endpoint Not Met". Berlin....
- [3] Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin....
- [4] Mologen AG. (3/18/19). "Press Release: Early Departure of CEO". Berlin....
- [5] Mologen AG. (1/17/19). "Press Release: Full Placement of Convertible Bond 2019/2027. Total Amount Issued: EUR2.7 Million, Maturity of 8 Years, Coupon of 6% p.a. [NOT FOR US, CA, JP, et al.]". Berlin....
- [6] Mologen AG. (11/16/18). "Press Release: Mologen AG to Retain Rights to Lefitolimod – Termination of Negotiations with Oncologie Inc. and Assessment of All Strategic Options in the Light of a Likely Read-out of the Pivotal Phase III IMPALA Trial in 2019"...
- [7] Mologen AG. (11/12/18). "Press Release: Lefitolimod – First Clinical Data in Combination with a Checkpoint Inhibitor and further Preclinical Results Presented at SITC 2018". Berlin....
- [8] Convert Pharmaceuticals S.A.. (11/8/18). "Press Release: Convert Pharmaceuticals Appoints Mariola Söhngen as New CEO"....
- [9] Mologen AG. (11/8/18). "Press Release: Implementation of Financing Measures and Publication of Study Results". Berlin....
- [10] Mologen AG. (9/27/18). "Press Release: Mologen AG Completes Capital Increase with Gross Proceeds of around EUR8 Million [NOT FOR RELEASE IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, et al.]". Berlin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top